array(64) { ["SERVER_SOFTWARE"]=> string(6) "Apache" ["REQUEST_URI"]=> string(47) "/instituto/idorinvestigation_areas/hematologia/" ["PHP_PATH"]=> string(24) "/opt/bitnami/php/bin/php" ["FREETDSLOCALES"]=> string(0) "" ["FREETDSCONF"]=> string(0) "" ["OPENSSL_ENGINES"]=> string(31) "/opt/bitnami/common/lib/engines" ["OPENSSL_CONF"]=> string(39) "/opt/bitnami/common/openssl/openssl.cnf" ["SSL_CERT_FILE"]=> string(52) "/opt/bitnami/common/openssl/certs/curl-ca-bundle.crt" ["CURL_CA_BUNDLE"]=> string(52) "/opt/bitnami/common/openssl/certs/curl-ca-bundle.crt" ["LDAPCONF"]=> string(42) "/opt/bitnami/common/etc/openldap/ldap.conf" ["GS_LIB"]=> string(43) "/opt/bitnami/common/share/ghostscript/fonts" ["MAGICK_CODER_MODULE_PATH"]=> string(60) "/opt/bitnami/common/lib/ImageMagick-6.9.8/modules-Q16/coders" ["MAGICK_CONFIGURE_PATH"]=> string(73) "/opt/bitnami/common/lib/ImageMagick-6.9.8/config-Q16:/opt/bitnami/common/" ["MAGICK_HOME"]=> string(19) "/opt/bitnami/common" ["PATH"]=> string(260) "/opt/bitnami/apps/wordpress/bin:/opt/bitnami/varnish/bin:/opt/bitnami/sqlite/bin:/opt/bitnami/php/bin:/opt/bitnami/mysql/bin:/opt/bitnami/letsencrypt/:/opt/bitnami/apache2/bin:/opt/bitnami/common/bin:/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin" ["USER"]=> string(6) "daemon" ["HOME"]=> string(9) "/usr/sbin" ["SCRIPT_NAME"]=> string(10) "/index.php" ["QUERY_STRING"]=> string(0) "" ["REQUEST_METHOD"]=> string(3) "GET" ["SERVER_PROTOCOL"]=> string(8) "HTTP/1.0" ["GATEWAY_INTERFACE"]=> string(7) "CGI/1.1" ["REDIRECT_URL"]=> string(47) "/instituto/idorinvestigation_areas/hematologia/" ["REMOTE_PORT"]=> string(5) "54665" ["SCRIPT_FILENAME"]=> string(44) "/opt/bitnami/apps/wordpress/htdocs/index.php" ["SERVER_ADMIN"]=> string(15) "[email protected]" ["CONTEXT_DOCUMENT_ROOT"]=> string(34) "/opt/bitnami/apps/wordpress/htdocs" ["CONTEXT_PREFIX"]=> string(0) "" ["REQUEST_SCHEME"]=> string(4) "http" ["DOCUMENT_ROOT"]=> string(34) "/opt/bitnami/apps/wordpress/htdocs" ["REMOTE_ADDR"]=> string(13) "18.228.86.237" ["SERVER_PORT"]=> string(2) "80" ["SERVER_ADDR"]=> string(11) "172.26.1.14" ["SERVER_NAME"]=> string(13) "54.225.48.228" ["SERVER_SIGNATURE"]=> string(0) "" ["LD_LIBRARY_PATH"]=> string(410) "/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/varnish/lib:/opt/bitnami/varnish/lib/varnish:/opt/bitnami/varnish/lib/varnish/vmods:/opt/bitnami/sqlite/lib:/opt/bitnami/mysql/lib:/opt/bitnami/apache2/lib:/opt/bitnami/common/lib:/opt/bitnami/common/lib64" ["HTTP_COOKIE"]=> string(157) "__cf_bm=8XyNRu9j4RZkevvrP3G8Q_g_aeEr5GzZU9TEbNxQCOc-1735574097-1.0.1.1-514R1eCq08vxbLsLA6IepR2zRMZIW9xSNIB2DvLuANTJv3vZsBtm84z_50j6aITx_TU8NaYwzImrqnpKdenHyQ" ["HTTP_CDN_LOOP"]=> string(19) "cloudflare; loops=1" ["HTTP_CF_CONNECTING_IP"]=> string(13) "3.138.137.244" ["HTTP_REFERER"]=> string(80) "http://www.rededorsaoluiz.com.br/instituto/idor/investigation_areas/hematologia/" ["HTTP_USER_AGENT"]=> string(103) "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; [email protected])" ["HTTP_ACCEPT"]=> string(3) "*/*" ["HTTP_CF_VISITOR"]=> string(22) "{\"scheme\":\"https\"}" ["HTTP_CF_RAY"]=> string(20) "8fa3361b499acf7f-GRU" ["HTTP_ACCEPT_ENCODING"]=> string(8) "gzip, br" ["HTTP_CF_IPCOUNTRY"]=> string(2) "US" ["HTTP_TRUE_CLIENT_IP"]=> string(13) "3.138.137.244" ["HTTP_X_AMZN_TRACE_ID"]=> string(40) "Root=1-6772c251-247ff0773129820f76b0b56f" ["HTTP_X_FORWARDED_PORT"]=> string(3) "443" ["HTTP_CONNECTION"]=> string(5) "close" ["HTTP_X_FORWARDED_PROTO"]=> string(4) "http" ["HTTP_X_FORWARDED_FOR"]=> string(41) "3.138.137.244, 172.71.238.4, 10.247.47.37" ["HTTP_X_REAL_IP"]=> string(12) "10.247.47.37" ["HTTP_X_FORWARDED_HOST"]=> string(25) "www.rededorsaoluiz.com.br" ["HTTP_HOST"]=> string(13) "54.225.48.228" ["SCRIPT_URI"]=> string(67) "http://54.225.48.228/instituto/idorinvestigation_areas/hematologia/" ["SCRIPT_URL"]=> string(47) "/instituto/idorinvestigation_areas/hematologia/" ["REDIRECT_STATUS"]=> string(3) "200" ["REDIRECT_SCRIPT_URI"]=> string(67) "http://54.225.48.228/instituto/idorinvestigation_areas/hematologia/" ["REDIRECT_SCRIPT_URL"]=> string(47) "/instituto/idorinvestigation_areas/hematologia/" ["FCGI_ROLE"]=> string(9) "RESPONDER" ["PHP_SELF"]=> string(10) "/index.php" ["REQUEST_TIME_FLOAT"]=> float(1735574097.7336) ["REQUEST_TIME"]=> int(1735574097) }

Hematologia

Home > Pesquisa > Áreas de Pesquisa

Hematologia

Home > Pesquisa > Áreas de Pesquisa
Busque por todo o site:

A grande capilaridade da RDSL é peça chave, também, da pesquisa do IDOR na área de hematologia, pois o substancioso volume de pacientes viabiliza, por exemplo, a realização de pesquisas com doenças pouco frequentes e o desenvolvimento de estudos que demandam grandes quantidades de dados.

Nesse sentido, a equipe de hematologia desenvolve estudos com dados do mundo real (real world data), que usam inteligência artificial para analisar os desfechos de milhares de pacientes e traduzir os resultados em avanço científico e melhoria do atendimento em saúde. Trabalhos com esse foco ajudam a entender o comportamento das drogas para além dos ensaios clínicos controlados, a partir da observação do que acontece no dia a dia dos hospitais, em situações que fogem aos protocolos.

Para além dos ensaios clínicos com novas moléculas, o IDOR vem se consolidando como centro de referência na pesquisa em terapias celulares, tendo participado de ensaios clínicos com terapias inovadoras como CarT-Cell para linfomas resistentes aos tratamentos atualmente disponíveis. Nessa nova proposta terapêutica, os pacientes são tratados com suas próprias células – mais especificamente, linfócitos T – que são coletadas e modificadas geneticamente para expressar receptores que reconhecem e atacam as células tumorais. A expertise adquirida em ensaios clínicos como esse permitirão ao IDOR, no futuro, desenvolver outras propostas de terapia celular.

Pesquisadores
Edvan de Queiroz Crusoé

Hematologia
Fábio Moore Nucci

Hematologia
Abel da Costa Neto

Hematologia
Rodrigo Nalio Ramos

Hematologia
Eduardo Magalhães Rego

Hematologia
Vanderson Rocha

Hematologia
Notícias Relacionadas

Pesquisa - Novidades

Falta de Recursos e Atraso Tecnológico Ainda São Obstáculos para Tratamento de Leucemia Mieloide Aguda na América Latina

Realizado com participação do IDOR, estudo analisa acessibilidade a diagnósticos e terapias para a doença em diversos países latino-americanos

07/12/2023

Pesquisa - Novidades

Patologia IDOR: Avanço tecnológico a favor da ciência translacional

Liderada pelo Dr. Fernando Soares, área conta com infraestrutura para exames moleculares complexos, abrindo espaço para diagnósticos mais precisos e pesquisas fundamentais para um melhor entendimento das doenças

04/10/2023

Pesquisa - Novidades

Estudo com participação do IDOR muda consenso científico no entendimento do papel de macrófagos no câncer de mama

Pesquisa aponta que macrófagos, antes associados a um mau prognóstico oncológico, podem ser chave […]

29/04/2022

Pesquisa - Novidades - Institucional

O IDOR, a Iniciativa Ciência Pioneira e o Instituto Weizmann de Ciências, em Israel, anunciam programa de bolsas de pós-doutorado para pesquisadores brasileiros

Colaboração entre instituições apoiada pela iniciativa Ciência Pioneira oferecerá 15 bolsas de pós-doutorado no […]

08/04/2022
Principais Publicações

Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. N Engl J Med. 2021 Jul 1;385(1):46-58. PMID: 34192431.

doi: 10.1056/NEJMoa2028631

Crusoé EQ, Pimenta FCF, Maiolino A, Castro NS, Pei H, Trufelli D, Fernandez M, Herriot LB. Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma. Hematol Transfus Cell Ther. 2021 Oct-Dec;43(4):417-423. Epub 2020 Sep 14. PMID: 32967807; PMCID: PMC8573022.

doi: 10.1016/j.htct.2020.07.005

Pessoa de Magalhães Filho RJ, Crusoe E, Riva E, Bujan W, Conte G, Navarro Cabrera JR, Garcia DK, Vega GQ, Macias J, Oliveros Alvear JW, Royg M, Neves LA, Lopez Dopico JL, Espino G, Ortiz DR, Socarra Z, Fantl D, Ruiz-Arguelles GJ, Maiolino A, Hungria VTM, Harousseau JL, Durie B. Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries. Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):e43-e50. Epub 2018 Aug 29. PMID: 30297171.

doi: 10.1016/j.clml.2018.08.005

Hungria VT, Crusoé EQ, Maiolino A, Bittencourt R, Fantl D, Maciel JF, Pessoa de Magalhaes RJ, Almeida MS, Cury P, Hisgashi F, Peres AL, Chiattone CS. Phase 3 trial of three thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant-eligible. Ann Hematol. 2016 Jan;95(2):271-8. Epub 2015 Oct 30. PMID: 26518211.

doi: 10.1007/s00277-015-2537-2

Ocio EM, Vilanova D, Atadja P, Maiso P, Crusoe E, Fernández-Lázaro D, Garayoa M, San-Segundo L, Hernández-Iglesias T, de Alava E, Shao W, Yao YM, Pandiella A, San-Miguel JF. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma. Haematologica. 2010 May;95(5):794-803. Epub 2009 Nov 30. PMID: 19951978; PMCID: PMC2864386.

doi: 10.3324/haematol.2009.015495
Kannan, Salim. Laboratórios com Interpretações clínicas – 1ª edição – Rio de Janeiro, 2019. ISBN 978-85-388-1013-1. Capítulo 32 – Estudo da Hemostasia – Autores: Fabio Moore Nucci e Luis José Daza López.

Viana LA, Cristelli MP, Santos DW, Tavares MG, Dantas MTC, Felipe CR, Silva HT, Pestana JM. Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: A retrospective cohort analysis. Am J Transplant. 2019 May;19(5):1421-1431.

doi: 10.1111/ajt.15220

Santos DW, Camargo LF, Gonçalves SS, Ogawa MM, Tomimori J, Enokihara MM, Medina-Pestana JO, Colombo AL. Melanized fungal infections in kidney transplant recipients: contributions to optimize clinical management. Clin Microbiol Infect. 2017 May;23(5):333.e9-333.e14. Epub 2017 Jan 3. PMID: 28062320.

doi: 10.1016/j.cmi.2016.12.024

Santos DWCL, Hagen F, Meis JF, Cristelli MP, Viana LA, Bernardi FDC, Tedesco-Silva H, Medina-Pestana JO, Colombo AL. Donor-Derived Transmission of Cryptococcus gattii sensu lato in Kidney Transplant Recipients. Emerg Infect Dis. 2020 Jun;26(6):1329-1331. PMID: 32441623; PMCID: PMC7258454.

doi: 10.3201/eid2606.191765

Santos DWCL, de Azevedo CMPES, Vicente VA, Queiroz-Telles F, Rodrigues AM, de Hoog GS, Denning DW, Colombo AL. The global burden of chromoblastomycosis. PLoS Negl Trop Dis. 2021 Aug 12;15(8):e0009611. PMID: 34383752; PMCID: PMC8360387.

doi: 10.1371/journal.pntd.0009611

Ramos RN, Rodriguez C, Hubert M, Ardin M, Treilleux I, Ries CH, Lavergne E, Chabaud S, Colombe A, Trédan O, Guedes HG, Laginha F, Richer W, Piaggio E, Barbuto JAM, Caux C, Ménétrier-Caux C, Bendriss-Vermare N. CD163+ tumor-associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes. Clin Transl Immunology. 2020 Feb 13;9(2):e1108. PMID: 32082570; PMCID: PMC7017151.

doi: 10.1002/cti2.1108

Leruste A, *Ramos RN, *Tosello J, Tauziède-Espariat A, Brohard S, Han ZY, Beccaria K, Andrianteranagna M, Caudana P, Nikolic J, Chauvin C, Niborski LL, Manriquez V, Richer W, Masliah-Planchon J, et al. Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors. Cancer Cell. 2019 Dec 9;36(6):597-612.e8. Epub 2019 Nov 7. PMID: 31708437. (*igual contribuição)

doi: 10.1016/j.ccell.2019.10.008

Bourdely P, Anselmi G, Vaivode K, Ramos RN, Missolo-Koussou Y, Hidalgo S, Tosselo J, Nuñez N, Richer W, Vincent-Salomon A, Saxena A, Wood K, Lladser A, Piaggio E, Helft J, Guermonprez P. Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells. Immunity. 2020 Aug 18;53(2):335-352.e8. Epub 2020 Jun 30. PMID: 32610077; PMCID: PMC7445430.

doi: 10.1016/j.immuni.2020.06.002

Nader GPF, Agüera-Gonzalez S, Routet F, Gratia M, Maurin M, Cancila V, Cadart C, Palamidessi A, Ramos RN, San Roman M, Gentili M, Yamada A, Williart A, Lodillinsky C, Lagoutte E, Villard C, Viovy JL, Tripodo C, Galon J, Scita G, Manel N, Chavrier P, Piel M. Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion. Cell. 2021 Sep 30;184(20):5230-5246.e22. Epub 2021 Sep 21. PMID: 34551315.

doi: 10.1016/j.cell.2021.08.035

Nalio Ramos R, Missolo-Koussou Y, Gerber-Ferder Y, Bromley CP, Bugatti M, Núñez NG, Tosello Boari J, Richer W, Menger L, Denizeau J, Sedlik C, Caudana P, Kotsias F, Niborski LL, Viel S, Bohec M, Lameiras S, Baulande S, Lesage L, Nicolas A, Meseure D, Vincent-Salomon A, Reyal F, Dutertre CA, Ginhoux F, Vimeux L, Donnadieu E, Buttard B, Galon J, Zelenay S, Vermi W, Guermonprez P, Piaggio E, Helft J. Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer. Cell. 2022 Mar 31;185(7):1189-1207.e25. Epub 2022 Mar 23. PMID: 35325594.

doi: 10.1016/j.cell.2022.02.021

Pagnano KB, Peralta EH, Navarro JR, David Salas LDR, Delgado N, Moiraghi B, Toreli ACM, Perobelli LM, Fechio L, Quixada ATS, Funke V, Bendit I, Seguro FS, Pilleux L, Bortolini J, Lourenço ALG, Sapelli J, Nucci FM, et al. COVID-19 in chronic myeloid leukemia patients in Latin America. Leuk Lymphoma. 2021 Dec;62(13):3212-3218. Epub 2021 Jul 13. PMID: 34254886.

doi: 10.1080/10428194.2021.1950709

Nucci F, Nouér SA, Capone D, Nucci M. Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis. Clin Microbiol Infect. 2018 Oct;24(10):1105.e1-1105.e4. Epub 2018 May 19. PMID: 29787890.

doi: 10.1016/j.cmi.2018.05.006

Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M. Fusariosis. Semin Respir Crit Care Med. 2015 Oct;36(5):706-14. Epub 2015 Sep 23. PMID: 26398537.

doi: 10.1055/s-0035-1562897

Axfors C, Janiaud P, Schmitt AM, Van’t Hooft J, Smith ER, Haber NA, Abayomi A, Abduljalil M, Abdulrahman A, Acosta-Ampudia Y, Aguilar-Guisado M, Al-Beidh F, Alejandria MM, Alfonso RN, Ali M, AlQahtani M, AlZamrooni A, Anaya JM, Ang MAC, Aomar IF, Argumanis LE, Averyanov A, Baklaushev VP, Balionis O, Benfield T, Berry S, Birocco N, Bonifacio LB, Bowen AC, Bown A, Cabello-Gutierrez C, Camacho B, Camacho-Ortiz A, Campbell-Lee S, Cao DH, Cardesa A, Carnate JM, Castillo GJJ, Cavallo R, Chowdhury FR, Chowdhury FUH, Ciccone G, Cingolani A, Climacosa FMM, Compernolle V, Cortez CFN, Costa Neto A, et al. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials. BMC Infect Dis. 2021 Nov 20;21(1):1170. PMID: 34800996; PMCID: PMC8605464.

doi: 10.1186/s12879-021-06829-7

Costa Neto, A, Moraes, BDGC, Rocha, IMG, Bezerra, FA, Medeiros, GOC, Alves, LBO, Rossetti, RAM, Fayh, APT, Mariano, LCB, & Rocha, V (2018). Association of Sarcopenia with Toxicities and Survival after Autologous Hematopoietic Stem Cell Transplantation for Adults with Lymphomas. Blood, 132(Supplement 1), 2158–2158.

doi: 10.1182/blood-2018-99-117717

da Silva WF, Neto AC, da Rosa LI, de Siqueira IA, Amarante GD, Velloso EDRP, Rego EM, Rocha V, Buccheri V. Outcomes and second neoplasms in hairy cell leukemia: A retrospective cohort. Leuk Res. 2019 Aug;83:106165. Epub 2019 Jun 4. PMID: 31200147.

doi: 10.1016/j.leukres.2019.06.001

Costa Neto A, Santos F, Ribeiro I, Oliveira V, Dezan M, Kashima S, Covas D, Pereira A, Fonseca G, Moreira F, Krieger J, Gualandro S, Rocha V, Mendrone A Jr, Dinardo CL. FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients. Transfusion. 2020 Jul;60(7):1573-1578. Epub 2020 May 4. PMID: 32681817

doi: 10.1111/trf.15832

Ortiz Rojas CA, Costa-Neto A, Pereira-Martins DA, Le DM, Sternadt D, Weinhäuser I, Huls G, Schuringa JJ, Magalhães Rego E. High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia. Cancers (Basel). 2022 Dec 31;15(1):296. PMID: 36612292; PMCID: PMC9818450.

doi: 10.3390/cancers15010296

Evangelista, A.F.; Vannier-Santos, M.A.; de Assis Silva, G.S.; Silva, D. N.; Juiz, P. J. L.; Nonaka, C. K. V.; Santos, R.R; Soares, M.B.P Villarreal, C. F.Bone marrow-derived mesenchymal stem/stromal cells reverse the sensorial diabetic neuropathy via modulation of spinal neuroinflammatory cascades. J Neuroinflammation 15, 189 (2018).

doi: 10.1186/s12974-018-1224-3

Nonaka, C.K.V.; Sampaio, G.L.; de Aragão França, L.; Cavalcante, B.R.; Silva, K.N.; Khouri, R.; Torres, F.G.; Meira, C.S.; de Souza Santos, E.; Macedo, C.T.; Paredes, B.D.; Rocha, V.P.C.; Rogatto, S.R.; Ribeiro dos Santos, R.; Souza, B.S.d.F.; Soares, M.B.P. Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease. Int. J. Mol. Sci. 2021, 22, 3307.

doi: 10.3390/ijms22073307

Nonaka, C.K.V.; Macêdo, C.T.; Cavalcante, B.R.R.; Alcântara, A.C.d.; Silva, D.N.; Bezerra, M.d.R.; Caria, A.C.I.; Tavora, F.R.F.; Neto, J.D.d.S.; Noya-Rabelo, M.M.; Rogatto, S.R.; Ribeiro dos Santos, R.; Souza, B.S.d.F.; Soares, M.B.P. Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy. Int. J. Mol. Sci. 2019, 20, 4064.

doi: 10.3390/ijms20164064

Improta Caria, A.C.; Nonaka, C.K.V.; Pereira, C.S.; Soares, M.B.P.; Macambira, S.G.; Souza, B.S.d.F. Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity. Int. J. Mol. Sci. 2018, 19, 3608.

doi: 10.3390/ijms19113608

Nonaka CKV, Franco MM, Gräf T, de Lorenzo Barcia CA, de Ávila Mendonça RN, de Sousa KAF, Neiva LMC, Fosenca V, Mendes AVA, de Aguiar RS, Giovanetti M, de Freitas Souza BS. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil. Emerg Infect Dis. 2021 May;27(5):1522-1524. Epub 2021 Feb 19. PMID: 33605869; PMCID: PMC8084516.

doi: 10.3201/eid2705.210191

Silveira DRA, Quek L, Santos IS, Corby A, Coelho-Silva JL, Pereira-Martins DA, Vallance G, Brown B, Nardinelli L, Silva WF, Velloso EDRP, Lucena-Araujo AR, Traina F, Peniket A, Vyas P, Rego EM, Bendit I, Rocha V. Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia. Blood Adv. 2020 May 26;4(10):2339-2350. PMID: 32453839

doi: 10.1182/bloodadvances.2019001419

Balassa K, Rocha V. Anticancer cellular immunotherapies derived from umbilical cord blood. Expert Opin Biol Ther. 2018 Feb;18(2):121-134. Epub 2017 Nov 9. PMID: 29103317 Review.

doi: 10.1080/14712598.2018.1402002

Buss LF, Prete CA Jr, Abrahim CMM, Mendrone A Jr, Salomon T, de Almeida-Neto C, França RFO, Belotti MC, Carvalho MPSS, Costa AG, Crispim MAE, Ferreira SC, Fraiji NA, Gurzenda S, Whittaker C, Kamaura LT, Takecian PL, da Silva Peixoto P, Oikawa MK, Nishiya AS, Rocha V, Salles NA, de Souza Santos AA, da Silva MA, Custer B, Parag KV, Barral-Netto M, Kraemer MUG, Pereira RHM, Pybus OG, Busch MP, Castro MC, Dye C, Nascimento VH, Faria NR, Sabino EC. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2021 Jan 15;371(6526):288-292. Epub 2020 Dec 8. PMID: 33293339; PMCID: PMC7857406.

doi: 10.1126/science.abe9728

Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A, Finel H, Chalandon Y, Kenzey C, Kharfan-Dabaja M, Labussière-Wallet H, Moraleda JM, Pastano R, Perales MA, El Ayoubi HR, Ruggeri A, Sureda A, Volt F, Yakoub-Agha I, Zhang MJ, Gluckman E, Montoto S, Eapen M. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. J Clin Oncol. 2020 May 10;38(14):1518-1526. Epub 2020 Feb 7. Erratum in: J Clin Oncol. 2020 Dec 1;38(34):4130. Erratum in: J Clin Oncol. 2021 Jan 20;39(3):258. PMID: 32031876; PMCID: PMC7213591.

doi: 10.1200/JCO.19.02408

Fatobene G, Volt F, Moreira F, Mariano L, Chevallier P, Furst S, Labussière-Wallet H, de la Tour RP, Deconinck E, Cluzeau T, Russell N, Karakasis D, Forcade E, Ruggeri A, Gluckman E, Rocha V. Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseases. Blood Adv. 2020 Dec 22;4(24):6327-6335. PMID: 33351128; PMCID: PMC7756987.

doi: 10.1182/bloodadvances.2020002258

Thomé CH, Ferreira GA, Pereira-Martins DA, Dos Santos GA, Ortiz CA, de Souza LEB, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Coelho-Silva JL, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, Kerbauy FR, Chauffaille ML, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Sci Rep. 2020 Jun 25;10(1):10315. PMID: 32587277; PMCID: PMC7316767.

doi: 10.1038/s41598-020-66223-2

Weinhäuser I, Pereira-Martins DA, Ortiz C, Silveira DR, Simões LAA, Bianco TM, Araujo CL, Koury LC, Melo RAM, Bittencourt RI, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria AB, Kerbauy F, Chauffaille ML, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Ammatuna E, Lucena-Araujo AR, Schuringa JJ, Rego EM. Reduced SLIT2 is Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in Acute Promyelocytic Leukemia. Cancers (Basel). 2020 Oct 27;12(11):3134.

doi: 10.3390/cancers12113134

Barna, M., Pusic, A., Zollo, O. , Costa, M., Kondrashov, N.,  Rego, E., Rao, P.H.,  Ruggero, D.. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 2008; 456, 971–975.

doi: 10.1038/nature07449

Rego EM, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte Mdel R, Jacomo RH, Gutiérrez- Aguirre H, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille Mde L, Chiattone CS, Martinez L, Meillón LA, Gómez-Almaguer D, Kwaan HC, Garcés-Eisele J, Gallagher R, Niemeyer CM, Schrier SL, Tallman M, Grimwade D, Ganser A, Berliner N,, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. Blood. 2013;121(11):1935-43

doi: 10.1182/blood-2012-08-449918

Rego EM, Wang ZG, Peruzzi D, He LZ, Cordon-Cardo C, Pandolfi PP. Role of promyelocytic leukemia (PML) protein in tumor suppression. J Exp Med. 2001;193(4):521-29.

doi: 10.1084/jem.193.4.521
Fale com a gente.